EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Are there racial/ethnic differences in antibiotic treatment of community acquired pneumonia in the inpatient setting?

Shana A B Burrowes iD, Mari-Lynn Drainoni, Tamar F Barlam

PLOS One · 25.03.2026 · 21 (3) · e0345788

DOI: 10.1371/journal.pone.0345788 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 25.03.2026. Verfasst von Shana A B Burrowes und 2 weiteren Autor:innen. Beteiligte Einrichtung: Section of Infectious Diseases, Department of Medicine, Boston Medical Center & Boston University Chobanian and Avedisian School of Medicine, Boston,…. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Community-Acquired Pneumonia. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Society for Healthcare Epidemiology of America.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Community Acquired Pneumonia (CAP) is the most common reason for antibiotic treatment in hospitalized adults. Some prior studies have found treatment differences by race/ethnicity, but research on the topic is limited, results are mixed, and it is unclear if clinical outcomes are affected.

Methods

We conducted a retrospective analysis of hospitalized patients >=18 years of age with a diagnosis of CAP from 2018–2021 across 457 US hospitals in the Vizient Inc. Clinical Data Base. We examined guideline concordant antibiotic treatment differences for inpatient CAP by patient race/ethnicity and hospital level factors and secondarily assessed whether treatment differences affect patient clinical outcomes.

Results

There were 1,277,770 admissions. Over half of all patients received concordant antibiotic therapy. Non-Hispanic Black patients had an increased odds of receiving guideline concordant antibiotic care (OR 1.22 95% CI 1.21–1.23) compared to non-Hispanic White patients. As the number of hospital beds increased, the odds of receiving concordant therapy decreased, with the greatest reduced odds between hospitals with >500 beds vs < 75 beds (OR 0.68, 95% CI 0.66–0.70). As case mix index increased concordant care decreased with the lowest odds observed at hospitals with a case mix index >2 (OR 0.71 95% CI 0.7–0.72). Patients at hospitals in the South (OR 0.8 95% CI 0.79–0.81) and Northeast (OR 0.71, 95% CI 0.7–0.72) were less likely than those in the West to receive concordant care. There was no significant association between the interaction of race/ethnicity and receipt of guideline concordant therapy and clinical outcomes.

Conclusion

Non-Hispanic Black patients were more likely to received guideline-concordant care for CAP however significant differences in concordant therapy were seen at the hospital level. Understanding the interplay of race/ethnicity and concordant CAP therapy at the individual and population level is important for future research in the examination of disparities in care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsCommunity-Acquired PneumoniaAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedEthnicityHospitalizationInpatientsRetrospective StudiesUnited States

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Section of Infectious Diseases, Department of Medicine, Boston Medical Center & Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of America.
  • Evans Center for Implementation and Improvement Sciences, Department of Medicine, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, United States of America.
  • Department of Health Law Policy and Management, Boston University School of Public Health, Boston, Massachusetts, United States of America.

ORCID-Profile: Shana A B Burrowes

Förderung

  • Society for Healthcare Epidemiology of America

Zitieren

APA

Burrowes, S. A. B., Drainoni, M. L., & Barlam, T. F. (2026). Are there racial/ethnic differences in antibiotic treatment of community acquired pneumonia in the inpatient setting?. PLOS One, 21(3), e0345788. https://doi.org/10.1371/journal.pone.0345788

Vancouver

Burrowes SAB, Drainoni ML, Barlam TF. Are there racial/ethnic differences in antibiotic treatment of community acquired pneumonia in the inpatient setting?. PLOS One. 2026;21(3):e0345788. doi:10.1371/journal.pone.0345788

BibTeX
@article{Burrowes2026,
  author = {Burrowes, Shana A B and Drainoni, Mari-Lynn and Barlam, Tamar F},
  title = {Are there racial/ethnic differences in antibiotic treatment of community acquired pneumonia in the inpatient setting?},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {3},
  pages = {e0345788},
  doi = {10.1371/journal.pone.0345788}
}
Kostenlos starten →